Tierney Saccavino | Investor Relations |
Ron Cohen | President and Chief Executive Officer |
Michael Gesser | Chief Financial Officer |
Boobalan Pachaiyappan | H.C. Wainwright |
Welcome to the Acorda Therapeutics Fourth Quarter and Year-End 2022 Financial and Business Update. [Operator Instructions] Please be advised that this call is being recorded at the company's request.
I will now introduce your host for today's call, Tierney Saccavino, at Acorda. Tierney, please go ahead.
Thank you, Emily, and good morning, everyone.